Last reviewed · How we verify
[14C]XZP-3287
At a glance
| Generic name | [14C]XZP-3287 |
|---|---|
| Sponsor | Xuanzhu Biopharmaceutical Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- [14C]XZP-3287 CI brief — competitive landscape report
- [14C]XZP-3287 updates RSS · CI watch RSS
- Xuanzhu Biopharmaceutical Co., Ltd. portfolio CI